Literature DB >> 13725493

Imipramine (tofranil) in mental health clinic and private practice.

B V EARLE, A M EARLE.   

Abstract

Entities:  

Keywords:  DEPRESSION/therapy; PSYCHOPHARMACOLOGY

Mesh:

Substances:

Year:  1960        PMID: 13725493      PMCID: PMC1938418     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  The treatment of depressive conditions with imipramine (G 22355).

Authors:  H E LEHMANN; C H CAHN; R L DE VERTEUIL
Journal:  Can Psychiatr Assoc J       Date:  1958-10

2.  An alarming side-effect of tofranil.

Authors:  H L ENGLISH
Journal:  Lancet       Date:  1959-06-13       Impact factor: 79.321

3.  A controlled trial of imipramine in treatment of depressive states.

Authors:  J R BALL; L G KILOH
Journal:  Br Med J       Date:  1959-11-21

4.  [A new drug (iminodibenzylic derivative, G 22355) in therapy of depressive states].

Authors:  C FAZIO; F GIBERTI; C LOEB
Journal:  Minerva Med       Date:  1958-08-18       Impact factor: 4.806

5.  The treatment of depressive states with G 22355 (imipramine hydrochloride).

Authors:  R KUHN
Journal:  Am J Psychiatry       Date:  1958-11       Impact factor: 18.112

6.  [Treatment of depressive states with special consideration of tofranil, a new antidepressant].

Authors:  P KIELHOLZ; R BATTEGAY
Journal:  Schweiz Med Wochenschr       Date:  1958-08-02

7.  Imipramine; a potent new anti-depressant compound.

Authors:  H AZIMA; R H VISPO
Journal:  Am J Psychiatry       Date:  1958-09       Impact factor: 18.112

8.  Clinical experience with imipramine (G22355) in the treatment of depression.

Authors:  A M MANN; A S MACPHERSON
Journal:  Can Psychiatr Assoc J       Date:  1959-01

9.  Imipramine (tofranil): a safe, effective antidepressant drug in private practice.

Authors:  M STRAKER
Journal:  Can Med Assoc J       Date:  1959-04-01       Impact factor: 8.262

10.  Depressive states and drugs. II. The study of phenelzine dihydrogen sulfate (nardil) in open psychiatric settings.

Authors:  G J SARWER-FONER; E K KORANYI; A MESZAROS; H GRAUER
Journal:  Can Med Assoc J       Date:  1959-12-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.